These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3250051)

  • 41. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats.
    Felicioli R; Saracchi I; Flagiello AM; Bartoli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [18] Terminal pyrrolidonecarboxylic acid: Cleavage with enzymes.
    Doolittle RF
    Methods Enzymol; 1972; 25():231-44. PubMed ID: 23014405
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation].
    Lun'shina EV; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2002; 65(3):3-5. PubMed ID: 12227092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate.
    Paoli F; Spignoli G; Pepeu G
    Psychopharmacology (Berl); 1990; 100(1):130-1. PubMed ID: 2153307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
    Ghittoni S; Orsucci O; Saviozzi A; Simonini P
    Ital Gen Rev Dermatol; 1978; 15(1):39-61. PubMed ID: 162287
    [No Abstract]   [Full Text] [Related]  

  • 46. L-pyrrolidone carboxylic acid content in mammalian epidermis and other tissues.
    Wolfersberger MG; Tabachnick J; Finkelstein BS; Levin M
    J Invest Dermatol; 1973 May; 60(5):278-81. PubMed ID: 4758733
    [No Abstract]   [Full Text] [Related]  

  • 47. Pyroglutamic aciduria: studies on the enzymic block and on the metabolic origin of pyroglutamic acid.
    Eldjarn L; Jellum E; Stokke O
    Clin Chim Acta; 1972 Sep; 40(2):461-76. PubMed ID: 5056146
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on insulin-like substances in Korean red ginseng.
    Takaku T; Kameda K; Matsuura Y; Sekiya K; Okuda H
    Planta Med; 1990 Feb; 56(1):27-30. PubMed ID: 2192378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diastereoselective syntheses of deoxydysibetaine, dysibetaine, and its 4-epimer.
    Langlois N; Le Nguyen BK
    J Org Chem; 2004 Oct; 69(22):7558-64. PubMed ID: 15497982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma pyroglutamic acid levels after oral administration of monosodium glutamate to human volunteers.
    Ghezzi P; Garattini S; Caccia S; Salmona M; Zanini MG
    Toxicol Lett; 1983 Feb; 15(2-3):123-9. PubMed ID: 6131548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [INTERFERENCE OF PYRROLIDONECARBOXYLIC ACID IN THE ACTIVITY OF SOME ANTIHISTAMINICS].
    DIMAGGIO G; CIACERI G
    Arch Ital Sci Farmacol; 1963 Apr; 13():181-2. PubMed ID: 14245139
    [No Abstract]   [Full Text] [Related]  

  • 52. Accumulation of 5-oxoproline in mouse tissues after inhibition of 5-oxoprolinase and administration of amino acids: evidence for function of the gamma-glutamyl cycle.
    Van Der Werf P; Stephani RA; Meister A
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1026-9. PubMed ID: 4151516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection by pyroglutamic acid and some of its newly synthesized derivatives against glutamate-induced seizures in mice.
    Beani L; Bianchi C; Baraldi PG; Manfredini S; Pollini GP
    Arzneimittelforschung; 1990 Nov; 40(11):1187-91. PubMed ID: 1982209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyroglutamate stimulates Na+ -dependent glutamate transport across the blood-brain barrier.
    Hawkins RA; Simpson IA; Mokashi A; Viña JR
    FEBS Lett; 2006 Aug; 580(18):4382-6. PubMed ID: 16844120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of pyrrolidone-pyroglutamic acid composition on blood flow in rat middle cerebral artery.
    Semkina GA; Matsievskii DD; Mirzoyan NR
    Bull Exp Biol Med; 2006 Jan; 141(1):51-2. PubMed ID: 16929963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the malabsorption syndromes. Inhibition of (Na+-K+) ATPase of small intestine microvilli by pyrrolidone carboxylic acid.
    Escobedo M; Cravioto J
    Clin Chim Acta; 1973 Dec; 49(2):147-51. PubMed ID: 4272536
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effects of an antiischemic drug combination and nimodipine on cerebral blood supply in a hemorrhagic stroke model in rats].
    Mirzoian NR; Gan'shina TS; Kurdiumov IN; Bero RS
    Eksp Klin Farmakol; 2008; 71(2):17-20. PubMed ID: 18488901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pyroglutamic acidemia in an adult patient.
    Creer MH; Lau BW; Jones JD; Chan KM
    Clin Chem; 1989 Apr; 35(4):684-6. PubMed ID: 2702756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Correlations of pharmacokinetics and pharmacodynamics of a combined preparation containing pyrrolidone and pyroglutamic acid].
    Sariev AK; Lun'shina EV; Zherdev VP; Mirzoian NR
    Eksp Klin Farmakol; 2006; 69(2):58-61. PubMed ID: 16845944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Function of glutathione in kidney via the gamma-glutamyl cycle.
    Meister A
    Med Clin North Am; 1975 May; 59(3):649-66. PubMed ID: 236410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.